Skip to main content

Annals of Oncology

  • ISSN: 0923-7534

Editor-In-Chief: Powles

Next planned ship date: February 7, 2024

  • 5 Year impact factor: 32.4
  • Impact factor: 50.5

An official Journal of the European Society for Medical Oncology and the official journal of the Japanese Society of Medical Oncology Annals of Oncology, the journal of the Eu… Read more

Subscription options

Next planned ship date:
February 7, 2024

Institutional subscription on ScienceDirect

Request a sales quote
An official Journal of the European Society for Medical Oncology and the official journal of the Japanese Society of Medical Oncology

Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.

Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

With a large international editorial board of experts who are leaders in their fields, Annals of Oncology aims at delivering the best communication on the fast moving, and continually evolving, global oncology landscape.